Anthropic confirms it runs a wet lab for AI-driven biology research
Anthropic has a wet biology lab in the Bay Area where it uses its AI models to run physical experiments. The lab focuses on fundamental biology, not drug discovery, and Anthropic also launched a verification program for bio researchers. This comes amid warnings about AI risks.
Anthropic's acquisition of Coefficient Bio in April signaled its entry into physical biology work. The lab operates like standard biotech facilities, combining in-house research with external collaborations. The company emphasizes fundamental biology rather than drug development, partly to avoid competing with pharmaceutical partners like Novo Nordisk.
Its new verification program grants vetted researchers access to advanced models, while published reports cover protein design acceleration and biomolecular modeling improvements. These moves come as Anthropic faces internal and external scrutiny over AI safety, including a researcher's resignation and warnings about existential risks.
This development could reshape how AI companies approach scientific research, potentially accelerating biological discoveries while raising questions about safety oversight. Researchers may gain powerful new tools, but the combination of AI-driven experimentation and dire risk warnings could heighten public concern. The balance between innovation and precaution will likely influence regulatory discussions and industry practices.